ATE335475T1 - Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion - Google Patents

Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion

Info

Publication number
ATE335475T1
ATE335475T1 AT02711877T AT02711877T ATE335475T1 AT E335475 T1 ATE335475 T1 AT E335475T1 AT 02711877 T AT02711877 T AT 02711877T AT 02711877 T AT02711877 T AT 02711877T AT E335475 T1 ATE335475 T1 AT E335475T1
Authority
AT
Austria
Prior art keywords
medication
producing
treatment
targeting agents
transplant function
Prior art date
Application number
AT02711877T
Other languages
English (en)
Inventor
Marc Bigaud
Volker Brinkmann
Tomasz Sablinski
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0104438A external-priority patent/GB0104438D0/en
Priority claimed from GB0105000A external-priority patent/GB0105000D0/en
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE335475T1 publication Critical patent/ATE335475T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT02711877T 2001-02-22 2002-02-21 Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion ATE335475T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0104438A GB0104438D0 (en) 2001-02-22 2001-02-22 Organic compounds
GB0105000A GB0105000D0 (en) 2001-02-28 2001-02-28 Organic compounds

Publications (1)

Publication Number Publication Date
ATE335475T1 true ATE335475T1 (de) 2006-09-15

Family

ID=26245749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711877T ATE335475T1 (de) 2001-02-22 2002-02-21 Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion

Country Status (11)

Country Link
US (2) US20040087662A1 (de)
EP (1) EP1368015B1 (de)
JP (1) JP4318921B2 (de)
CN (1) CN100479814C (de)
AT (1) ATE335475T1 (de)
BR (1) BR0207434A (de)
CA (1) CA2435739A1 (de)
DE (1) DE60213766T2 (de)
ES (1) ES2267993T3 (de)
PT (1) PT1368015E (de)
WO (1) WO2002067915A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476623B2 (ja) * 2001-06-08 2010-06-09 ノバルティス アーゲー インスリン産生細胞移植片拒絶の処置または予防
DE60328161D1 (de) 2002-01-11 2009-08-13 Daiichi Sankyo Co Ltd Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
WO2005079788A1 (ja) 2004-02-24 2005-09-01 Sankyo Company, Limited アミノアルコール化合物
US7781617B2 (en) * 2004-07-16 2010-08-24 Kyorin Pharmaceutical Co., Ltd Effective use method of medicaments and method of preventing expression of side effect
EP2511262B1 (de) * 2004-10-12 2017-02-01 Kyorin Pharmaceutical Co., Ltd. Verfahren zur herstellung von 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorphenyl]ethyl]-1,3-propandiol-hydrochlorid
PT1932522E (pt) * 2005-10-07 2012-06-26 Kyorin Seiyaku Kk Agente terapêutico para doenças do fígado contendo, como princípio activo, um derivado de 2- amino-1,3-propanodiol
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
MY146775A (en) * 2006-08-08 2012-09-28 Kyorin Seiyaku Kk Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
SG174028A1 (en) * 2006-08-08 2011-09-29 Kyorin Seiyaku Kk Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
US8476305B2 (en) 2008-02-07 2013-07-02 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928572A (en) * 1971-02-11 1975-12-23 Ayerst Mckenna & Harrison Myriocin and process of preparation
WO1994008943A1 (fr) * 1992-10-21 1994-04-28 Yoshitomi Pharmaceutical Industries, Ltd. Compose 2-amino-1,3-propanediol et immunosuppresseur
HU224814B1 (en) * 1995-12-28 2006-02-28 Mitsubishi Pharma Corp Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
USRE39072E1 (en) * 1997-04-04 2006-04-18 Mitsubishi Pharma Corporation 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
JP4476623B2 (ja) * 2001-06-08 2010-06-09 ノバルティス アーゲー インスリン産生細胞移植片拒絶の処置または予防

Also Published As

Publication number Publication date
JP4318921B2 (ja) 2009-08-26
CN1492757A (zh) 2004-04-28
US20080015261A1 (en) 2008-01-17
DE60213766D1 (de) 2006-09-21
WO2002067915A1 (en) 2002-09-06
CN100479814C (zh) 2009-04-22
DE60213766T2 (de) 2007-08-02
US20040087662A1 (en) 2004-05-06
EP1368015A1 (de) 2003-12-10
JP2004527490A (ja) 2004-09-09
HK1060855A1 (en) 2004-08-27
CA2435739A1 (en) 2002-09-06
ES2267993T3 (es) 2007-03-16
PT1368015E (pt) 2006-12-29
BR0207434A (pt) 2004-07-06
EP1368015B1 (de) 2006-08-09

Similar Documents

Publication Publication Date Title
CO5221115A1 (es) Nuevos compuestos fungicidas
CY1116107T1 (el) Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων
TW200714283A (en) Method and composition for treating peripheral vascular diseases
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
ATE539701T1 (de) Zusammengesetzte schlinge zur behandlung von inkontinenz
ATE322681T1 (de) Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
WO2004039248A3 (en) Repairing or replacing tissues or organs
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
EA200802213A1 (ru) Способы лечения заболеваний крови
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
ATE404229T1 (de) Körper zum erzeugen von knochenwachstum und/oder bindegewebe und verfahren zur herstellung solches körpers
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ES2530872T3 (es) Organos y células modificados para xenotrasplante
ATE335475T1 (de) Verwendung von beschleunigten lymphozyten zielansteuernden wirkstoffen zur herstellung eines medikaments für die behandlung der verzögertern transplantat-funktion
DE69901569D1 (de) Humane antikörper gegen faktor ix/ixa
ATE417921T1 (de) Herstellung von tacrolimus (fk-506) unter verwendung neuer streptomyces-spezies
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
EP1599128A4 (de) Verfahren zur behandlung von erkrankungen durch transplantation von entwickelnden allogenen oder xenogenen organen oder geweben
ECSP055965A (es) Oxatiincarboxamidas
BR0316245A (pt) Atividade antimicrobiana de espécie de oxigênio reativo produtora de anticorpos
DE69930419D1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
GB0029410D0 (en) Embalming fluid
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
ATE399199T1 (de) Verwendung eines reinigungsmittelkonzentrats und verfahren zur reinigung chirurgischer instrumente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368015

Country of ref document: EP

REN Ceased due to non-payment of the annual fee